Contribution of Posterior Tibial Nerve Stimulation in the management of Urinary Disorders in idiopathic Parkinson's Disease: Experience of the National Hospital Center of Pikine

Abstract Introduction: Lower urinary tract symptoms (LUTS) are common during Parkinson's Disease (PD), but their management has not been clearly defined. Objectifs: Evaluate the efficacy of posterior tibial nerve stimulation in the management of LUTS in patients with PD Methods We conducted a prospective and comparative study from January to July 2025 at the Neurology Department of Pikine National Hospital. All patients with PD who complained of LUTS were included in the study. They were divided into two groups: one received posterior tibial nerve stimulation (PTNS), and the other received medical treatment. Patients undergoing stimulation received two 30-minute stimulation sessions per week for a total of six weeks. LUTS were assessed using the International Prostate Symptom Scale (IPSS) at 0, 6, and 12 weeks. Statistical analyses were performed using SPSS version 26.0. Results A total of 88 patients with MPI were seen, of whom 37 had LUTS, giving a frequency of 42.5%. The most common urinary symptoms were nocturia and pollakiuria, followed by urgency and incontinence. The IPSS score was higher in patients undergoing stimulation. PTNS resulted in a decrease in the IPSS score in all patients at 6 weeks and in 80% of patients at 12 weeks. The quality of life of patients undergoing stimulation improved at 6 and 12 weeks. There was no significant change in IPSS score and quality of life at 6 and 12 weeks between patients undergoing PTNS and those receiving drug treatment. Conclusion LUTS are frequent in Parkinson’s disease and negatively impact quality of life. PTNS improves urinary symptoms and quality of life, showing comparable efficacy to drug therapy, and represents a safe, non-invasive treatment option. Further studies are needed to confirm its long-term benefits.

Authors

Institutions

Publication Details

Journal
Research Square
Published
2026-11-16
DOI
https://doi.org/10.21203/rs.3.rs-11176736/v1
Primary Topic
Urinary Bladder and Prostate Research
Type
preprint
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

Contribution of Posterior Tibial Nerve Stimulation in the management of Urinary Disorders in idiopathic Parkinson's Disease: Experience of the National Hospital Center of Pikine

Maouly Fall, Jamil Kahwagi, Mark Olivier Ngoule, Serigne Abdoulaye Sow et al.
2 links
Research Square
Urinary Bladder and Prostate Research
preprint

Contribution of Posterior Tibial Nerve Stimulation in the management of Urinary Disorders in idiopathic Parkinson's Disease: Experience of the National Hospital Center of Pikine

Maouly Fall, Jamil Kahwagi, Mark Olivier Ngoule, Serigne Abdoulaye Sow, Cecilia Kwama, Alassane Diop, Mame Diarra Dia, Falonne NIAKAM, Assette Gnilane FAYE, Salima KAMALI, Matimé BOUKOULOU, Noelar MUNDIH, Aimé NGASSAKI, Candice M. SAMBA, Moustapha NIDIAYE, Claude B. BANGWENI
preprint en

Abstract

Abstract Introduction: Lower urinary tract symptoms (LUTS) are common during Parkinson's Disease (PD), but their management has not been clearly defined. Objectifs: Evaluate the efficacy of posterior tibial nerve stimulation in the management of LUTS in patients with PD Methods We conducted a prospective and comparative study from January to July 2025 at the Neurology Department of Pikine National Hospital. All patients with PD who complained of LUTS were included in the study. They were divided into two groups: one received posterior tibial nerve stimulation (PTNS), and the other received medical treatment. Patients undergoing stimulation received two 30-minute stimulation sessions per week for a total of six weeks. LUTS were assessed using the International Prostate Symptom Scale (IPSS) at 0, 6, and 12 weeks. Statistical analyses were performed using SPSS version 26.0. Results A total of 88 patients with MPI were seen, of whom 37 had LUTS, giving a frequency of 42.5%. The most common urinary symptoms were nocturia and pollakiuria, followed by urgency and incontinence. The IPSS score was higher in patients undergoing stimulation. PTNS resulted in a decrease in the IPSS score in all patients at 6 weeks and in 80% of patients at 12 weeks. The quality of life of patients undergoing stimulation improved at 6 and 12 weeks. There was no significant change in IPSS score and quality of life at 6 and 12 weeks between patients undergoing PTNS and those receiving drug treatment. Conclusion LUTS are frequent in Parkinson’s disease and negatively impact quality of life. PTNS improves urinary symptoms and quality of life, showing comparable efficacy to drug therapy, and represents a safe, non-invasive treatment option. Further studies are needed to confirm its long-term benefits.

Research Square
Cheikh Anta Diop University (SN)
Good health and well-being
Urinary Bladder and Prostate Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon